Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Antagonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00142727
What this trial is testing

Opioid Agonist and Antagonist Effects on Opioid Dependence

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA) 16
Testing effectiveness (Phase 2)Study completedNCT05546515
What this trial is testing

Suvorexant for Opioid/Stimulant Co-use

Who this might be right for
Opioid Use DisorderStimulant Use Disorder
Johns Hopkins University 20
Testing effectiveness (Phase 2)Ended earlyNCT03087708
What this trial is testing

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662720
What this trial is testing

A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Glycyx Therapeutics 18
Not applicableStudy completedNCT01878019
What this trial is testing

Brain Response to Pain Control in People With Chronic Pain

Who this might be right for
Pain
National Center for Complementary and Integrative Health (NCCIH) 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05382091
What this trial is testing

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

Who this might be right for
Opioid Use Disorder
Go Medical Industries Pty Ltd 250
Testing effectiveness (Phase 2)Study completedNCT01004393
What this trial is testing

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Who this might be right for
NeoplasmsConstipationOpioid-Related Disorders
University of Vermont 12
Testing effectiveness (Phase 2)Study completedNCT00460239
What this trial is testing

Buprenorphine's Dose Response Curve

Who this might be right for
Opioid-related Disorders
Johns Hopkins University 12
Large-scale testing (Phase 3)Ended earlyNCT02811783
What this trial is testing

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Who this might be right for
Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome
Elorac, Inc. 59
Post-approval studies (Phase 4)Study completedNCT01191645
What this trial is testing

Opioid Effects on Swallowing and Esophageal Sphincter Pressure

Who this might be right for
Opioid Induced Pharyngeal and Esophageal Dysfunction
Region Örebro County 14
Large-scale testing (Phase 3)Study completedNCT03518021
What this trial is testing

Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital

Who this might be right for
OverdoseDrug Abuse
Norwegian University of Science and Technology 286
Post-approval studies (Phase 4)Study completedNCT02445339
What this trial is testing

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Who this might be right for
Alcohol DependenceAlcohol Use Disorder
NYU Langone Health 50
Post-approval studies (Phase 4)Study completedNCT07558044
What this trial is testing

Ketamine Gargle for Pain After Pediatric Tonsillectomy

Who this might be right for
Postoperative PainTonsillectomyAdenotonsillectomy
Hospital Universitario de Caracas 420
Testing effectiveness (Phase 2)Study completedNCT01275755
What this trial is testing

Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Who this might be right for
Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 81
Not applicableStudy completedNCT03638440
What this trial is testing

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

Who this might be right for
Opioid Induced Constipation
Kyowa Kirin Pharmaceutical Development Ltd 183
Early research (Phase 1)Looking for participantsNCT05968690
What this trial is testing

Naltrexone and Propranolol Combined With Immunotherapy

Who this might be right for
Advanced Melanoma
Sarah Weiss 12
Not applicableStudy completedNCT02557984
What this trial is testing

Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity

Who this might be right for
Addiction
University of Zurich 121
Early research (Phase 1)Study completedNCT01935206
What this trial is testing

Effect of High Dose Naloxone on Secondary Hyperalgesia

Who this might be right for
HyperalgesiaPainNaloxone+1 more
Rigshospitalet, Denmark 15
Testing effectiveness (Phase 2)Study completedNCT03278886
What this trial is testing

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

Who this might be right for
HIV InfectionAlcohol UsePain
Boston Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06981195
What this trial is testing

Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects

Who this might be right for
Opioid Use DisorderOpioid UseInsomnia+1 more
Virginia Commonwealth University 100
Next Page